Topical formulation for binding to dermatological cannabinoid receptors
OwnerJessica Kadoinventor
Life of this patent
Estimating the term…
Abstract
A topical cream or ointment is provided that provides for the binding to CB1 and/or CB2 receptors for the soothing of pain, inflammation of smooth muscle, tendons, ligaments, skeletal muscle, endothelial cell, synovial cell, peripheral nerve fibers, reduction of endothelial bruising, promotion of healing of endothelial bruising, and dermatological itch sensation wherein the improvement comprises providing the effect of cannabinoid using plant extracts.
Claims15
A topical cream or ointment that provides for binding to CB1 and/or CB2 receptors for soothing of pain, inflammation of smooth muscle, tendons, ligaments, skeletal muscle, endothelial cells, synovial cells, peripheral nerve fibers, reduction of endothelial bruising, promotion of healing of endothelial bruising, and suppression of dermatological itch sensation, comprising:
- plant extracts having a cannabinoid effect;
- and
- emulsifiers and/or surfactants selected from the group consisting of:
- Polysorbate 20, Polysorbate 80, Polyacrylate-13, and combinations thereof.
A topical cream or ointment, comprising:
- plant extract components configured to bind to CB1 and/or CB2 receptors for soothing of pain, inflammation of smooth muscle, tendons, ligaments, skeletal muscle, endothelial cells, synovial cells, peripheral nerve fibers, reduction of endothelial bruising, promotion of healing of endothelial bruising, and suppression of dermatological itch sensation, and
- emulsifiers and/or surfactants selected from the group consisting of:
- Polysorbate 20, Polysorbate 80, Polyacrylate-13, and combinations thereof.
Dependencies are inferred from the claim text.